Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

28.20 +0.05 (+0.18%)
Streaming Delayed Price Updated: 12:53 PM EDT, Aug 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
News headline image
Hims HIMS Q1 2026 Earnings Call Transcript ↗
Hims HIMS Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Economy
Hims & Hers Health (NYSE:HIMS) Misses Q1 2026 Estimates, Shares Drop on GLP-1 Pivot Costs ↗
Via Chartmill
News headline image
Hims & Hers Health (NYSE:HIMS) Misses Q1 CY2026 Sales Expectations, Stock Drops 11.5%
Telehealth company Hims & Hers Health (NYSE:HIMS) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 3.8% year on year to $608.1 million. O... 
Via StockStory
News headline image
Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
From Hims & Hers
Via Business Wire
News headline image
Hims & Hers Health (HIMS) Reports Q1: Everything You Need To Know Ahead Of Earnings
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after the bell. Here’s what to expect. Hims & Hers Health met analyst... 
Via StockStory
Topics Artificial Intelligence
News headline image
Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus ↗
As Hims & Hers pivots to branded GLP-1s via a Novo Nordisk deal, all eyes are on the company’s May 11 earnings as investors look for sustained subscriber growth. 
Via MarketBeat
News headline image
What the FDA's Latest Proposal Means for Lilly, Novo, and Hims ↗
The FDA's latest proposal would be a win for Eli Lilly and Novo Nordisk, while Hims & Hers Health would also garner indirect benefits. 
Via MarketBeat
News headline image
1 Stock Under $50 with Impressive Fundamentals and 2 We Ignore
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
1 Russell 2000 Stock Worth Your Attention and 2 That Underwhelm
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,... 
Via StockStory
Topics Retirement
News headline image
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today
What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 4% in the afternoon session after the stock's momentum weakened as Amazon.com... 
Via StockStory
News headline image
Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance Means ↗
Via MarketBeat
News headline image
Hims & Hers Nominates Kofi Amoo-Gottfried to its Board of Directors
From Hims & Hers
Via Business Wire
News headline image
SpaceX Goes on $60 Billion AI Buying Spree ↗
SpaceX is buying another AI company, but does this mean it can catch up to Google, Anthropic, or OpenAI? 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
News headline image
Why Is Hims & Hers Health (HIMS) Stock Soaring Today
What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 9.6% in the afternoon session after JPMorgan initiated coverage on the comp... 
Via StockStory
Topics World Trade
News headline image
3 Market-Beating Stocks to Research Further
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta y... 
Via StockStory
News headline image
Stock Market Today, April 21: Hims & Hers Health Drops as Amazon Unveils Competing Weight Loss Program ↗
Telehealth investors weigh Amazon’s new anti-obesity drug push against this platform’s recent rapid growth, today, April 21, 2026. 
Via The Motley Fool
Topics Stocks
News headline image
A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly ↗
There might be room for two titans in the obesity business, but a third player might have a uniquely marketable option. 
Via The Motley Fool
News headline image
What's Going On With Hims & Hers Shares ↗
Shares of Hims & Hers Health Inc. (NASDAQ: HIMS) are rising Friday on the momentum from U.S. drug regulators easing restrictions on peptides. 
Via Benzinga
News headline image
Stock Market Today, April 16: Hims & Hers Health Jumps on FDA Review of Compounded Peptide Therapies ↗
On April 16, 2026, investors monitored an FDA peptide review that could be a boost to Hims & Hers Health. 
Via The Motley Fool
Topics Stocks
News headline image
Q4 Earnings Outperformers: Hims & Hers Health (NYSE:HIMS) And The Rest Of The Healthcare Technology Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Hims & Hers Health (NYSE:HIMS) and its peer... 
Via StockStory
News headline image
Hims & Hers to Announce First Quarter 2026 Financial Results on May 11, 2026
From Hims & Hers
Via Business Wire
News headline image
Did Hims & Hers Just Become an AI Company? ↗
Artificial intelligence could be a big differentiator for Hims & Hers. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 Profitable Stocks with Exciting Potential and 1 We Ignore
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
3 Sectors to Buy While They're Down and 1 to Walk Away From ↗
When the S&P 500 was flirting with 7,000 back in January, everyone wanted in. Now, with the index 400 to 500 points lower, the mood has flipped to fear. That disconnect between price and psychology is... 
Via MarketBeat
Topics Stocks
News headline image
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Should You Buy Hims Stock Today? ↗
The healthcare industry is ripe for disruption, and Hims is making early progress in this effort. 
Via The Motley Fool
News headline image
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after reports revealed that the US may impose up to 100% tariffs on imports of branded and pa... 
Via StockStory
Topics Government Stocks World Trade
News headline image
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Government Stocks
News headline image
2 Mooning Stocks on Our Buy List and 1 Facing Challenges
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u... 
Via StockStory
Topics Initial Public Offering
< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.